Some good news for dealmakers through the various earnings seasons around the world.
Australian upstart Barrenjoey’s pretty swift move to profitability follows Jarden’s news earlier this year of black ink on the other side of the Tasman (despite much sniping about the Kiwi’s Aussie foray) as the young Turks shook things up during the covid pandemic.
Enjoying the initial boom when free money seemed to fuel everything, there were a couple of cooler years for both investment banks, but there are signs of life in dealmaker-land (obviously helped in part as central bankers start loosening their grips on the monetary tillers).
Not only did PwC New Zealand’s recent M&A report show a pick-up in deal flow through the June quarter, but we’ve also got a few live takeovers on the go, such as with Arvida Group Limited, Vital NZ, and asset sales from Fletcher Building and Fonterra.
Investment banking in general seemed to be on the mend from the major banks reporting around the world in recent weeks.
UBS and Barclays both booked higher advisory fees and their trading desks benefited from the market volatility.
Meanwhile, Wall Street’s majors – Goldman Sachs, JPMorganChase, Bank of America, Morgan Stanley, Citi and Wells Fargo – all posted double-digit revenue growth at their investment banking divisions with M&A activity on the up and trading desks keeping busy.
It might just be the start of the recovery, but here’s hoping the easier monetary policy helps free things up some.
https://lnkd.in/grXq5KkV
Investment Banker | Managing Director at CC Capital Advisors | M&A
1moCongrats to Trent, who has become an incredibly valuable member of our team!